Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ASMB -12% on HBV data at AASLD (#msg-152206740). Curiously, ASMB’s share price rose 29% when the abstracts for today’s presentation were released one month ago (#msg-151738904).
Tue, 20 Oct 2015 08:02:01 GMT ~ Assembly Biosciences to Describe Improved Methods for HBV Drug Development at Major International Meeting
[at noodls] - - Data to Be Presented at 2015 International Meeting on the Molecular Biology of Hepatitis B Describes Improved Methods for Measuring Key Biomarkers for Curative Therapies- - Assembly Also Reporting New ...
Tue, 06 Oct 2015 11:00:00 GMT ~ Assembly Biosciences to Describe Improved Methods for HBV Drug Development at Major International Meeting
[GlobeNewswire] - —Data to Be Presented at 2015 International Meeting on the Molecular Biology of Hepatitis B Describes Improved Methods for Measuring Key Biomarkers for Curative Therapies—. —Assembly Also Reporting New ...
Link: http://www.otcmarkets.com/stock/ASMB/company-info Ticker: $ASMB OTC Market Place: Not Available CIK code: not found Company name: Assembly Biosciences, Inc. Incorporated In:
Business Description:
$ASMB share structure
## source: otcmarkets.com
Market Value: $44,172,139 a/o Nov 13, 2015 Shares Outstanding: 4,679,252 a/o Jul 14, 2014 Float: Not Available Authorized Shares: Not Available Par Value: Not Available